| Rogerson Orthopedic Appliances Inc | |
| 483 Southampton St, Boston, Massachusetts 02127 | |
| (617) 268-1135 |
| Name | Rogerson Orthopedic Appliances Inc |
|---|---|
| Organization Name | Rogerson Orthopedic Appliances Inc |
| Location | 483 Southampton St, Boston, Massachusetts 02127 |
| Type | Prosthetic/Orthotic Supplier |
| Phone | (617) 268-1135 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
CTI BioPharma Corp. today announced findings from an investigator-sponsored Phase 2 trial in patients with either primary (de novo) acute myeloid leukemia (AML) or AML that has evolved from myelodysplastic syndrome (MDS). Results showed the combination of tosedostat with low dose cytarabine/Ara-C (LDAC) resulted in an overall response rate (ORR) of 54 percent in elderly patients with AML – with 45 percent of patients achieving durable complete responses (CR).
WaferGen Biosystems, Inc., a leading developer of state-of-the-art genomic analysis systems, today announced the closing of a $7.2 million registered direct offering. The amount raised includes $1 million from the Chairman and CEO, Alnoor Shivji, and approximately $500,000 in the aggregate from four other members of the board of directors of WaferGen.
A study by the Autonomous University of Barcelona (UAB in Spanish) and Ramón Llull University have researched the relationship between the sleeping habits, hours slept, and academic performance of children aged between six and seven years of age. Experts have found that sleeping less than nine hours, going to bed late and no bedtime routine generally affects children's academic skills.
Two University of Adelaide pharmacologists working with one the world's leading neuroscientists have helped pave the way for the development of new pain-killing drugs that are not addictive.
› Verified 8 days ago
| NPI Number | 1619969037 |
| Organization Name | ROGERSON ORTHOPEDIC APPLIANCES INC |
| Type | Prosthetic/Orthotic Supplier |
| Address | 483 Southampton St, Boston, MA 02127 |
| Phone Number | 617-268-1135 |
News Archive
CTI BioPharma Corp. today announced findings from an investigator-sponsored Phase 2 trial in patients with either primary (de novo) acute myeloid leukemia (AML) or AML that has evolved from myelodysplastic syndrome (MDS). Results showed the combination of tosedostat with low dose cytarabine/Ara-C (LDAC) resulted in an overall response rate (ORR) of 54 percent in elderly patients with AML – with 45 percent of patients achieving durable complete responses (CR).
WaferGen Biosystems, Inc., a leading developer of state-of-the-art genomic analysis systems, today announced the closing of a $7.2 million registered direct offering. The amount raised includes $1 million from the Chairman and CEO, Alnoor Shivji, and approximately $500,000 in the aggregate from four other members of the board of directors of WaferGen.
A study by the Autonomous University of Barcelona (UAB in Spanish) and Ramón Llull University have researched the relationship between the sleeping habits, hours slept, and academic performance of children aged between six and seven years of age. Experts have found that sleeping less than nine hours, going to bed late and no bedtime routine generally affects children's academic skills.
Two University of Adelaide pharmacologists working with one the world's leading neuroscientists have helped pave the way for the development of new pain-killing drugs that are not addictive.
› Verified 8 days ago
News Archive
CTI BioPharma Corp. today announced findings from an investigator-sponsored Phase 2 trial in patients with either primary (de novo) acute myeloid leukemia (AML) or AML that has evolved from myelodysplastic syndrome (MDS). Results showed the combination of tosedostat with low dose cytarabine/Ara-C (LDAC) resulted in an overall response rate (ORR) of 54 percent in elderly patients with AML – with 45 percent of patients achieving durable complete responses (CR).
WaferGen Biosystems, Inc., a leading developer of state-of-the-art genomic analysis systems, today announced the closing of a $7.2 million registered direct offering. The amount raised includes $1 million from the Chairman and CEO, Alnoor Shivji, and approximately $500,000 in the aggregate from four other members of the board of directors of WaferGen.
A study by the Autonomous University of Barcelona (UAB in Spanish) and Ramón Llull University have researched the relationship between the sleeping habits, hours slept, and academic performance of children aged between six and seven years of age. Experts have found that sleeping less than nine hours, going to bed late and no bedtime routine generally affects children's academic skills.
Two University of Adelaide pharmacologists working with one the world's leading neuroscientists have helped pave the way for the development of new pain-killing drugs that are not addictive.
› Verified 8 days ago
Cvs Pharmacy #02971 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 350 Longwood Ave, Boston, Massachusetts 02115 Phone: (617) 731-8665 | |
Cvs Pharmacy #02516 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 35 Kneeland St, Boston, Massachusetts 02111 Phone: (617) 542-1885 | |
Cvs Pharmacy #11274 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 780 Albany St, Boston, Massachusetts 02118 Phone: (617) 638-0030 | |
Boston Medical Center Outpatient Pa Type: Community/Retail Pharmacy Location: 725 Albany St, Boston, Massachusetts 02118 Phone: (617) 414-4880 | |
Cvs Pharmacy #01258 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 191-193 Cambridge St, Boston, Massachusetts 02114 Phone: (617) 367-0441 |